Novartis Smacked With $10.5M Verdict In Jaw Injury Suit

Law360, New York (November 5, 2012, 5:11 PM EST) -- A New York federal jury hit Novartis Pharmaceuticals Corp. with a $10.5 million verdict Friday in a suit brought by a woman whose jaw deteriorated after she took the bone drug Zometa, snapping a string of victories for the company in multidistrict litigation over the drug.

Plaintiff Barbara Davids won $450,000 in compensatory damages and $10 million in punitive damages, John Vecchione of Valad & Vecchione PLLC told Law360 on Monday.

The jury found Novartis failed to warn Davids that Zometa could cause osternecrosis of the...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Davids et al v. Novartis Pharmaceuticals Corporation


Case Number

2:06-cv-00431

Court

New York Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

Arthur D. Spatt

Date Filed

January 31, 2006

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.